Scenarios that move TVRD

Tvardi Therapeutics, Inc. - Common Stock

Scenarios that move TVRD: 1 analysis, 0 positive, 1 negative.

1. 2026-10-14 · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▼ · impact -30 · confidence low · horizon immediate

All scenarios · Run a scenario · Pricing